Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment: A Systematic Review and Meta-Analysis
JAMA Dermatol 2023 Sep 06;[EPub Ahead of Print], Y Du, W Wu, M Chen, Z Dong, F WangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.